PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#ANAGRELIDE ×

UPDATED
Regulatorische Updates
30. Aug. 2026•1 Min. Lesezeit
FDA Approves ANAGRELIDE (ANDA076811)
FDA has approved the generic oral capsule ANAGRELIDE under ANDA076811, covering 0.5 mg and 1 mg strengths, sponsored by Novitum Pharma and manufactured by ANI Pharmaceuticals.